Sleep & Respiratory Newsletter
June 2018
In this issue
| |
| |
| |
Satellite Symposium: noninvasive COPD screening of expiratory flow limitation within home therapy
Symposium sponsored by Philips Respironics ERCA–JIVD 3rd Joint International Meeting, Lyon, France, March 2018 Tidal expiratory flow (EFL) limitation can occur in COPD patients when they exercise, or in more severe cases, when they aren’t exercising – in either case creating what is sometimes described as a “severe mechanical constraint.”1 Recently Peter Calverley and Raffaele L. Dellacà led a symposium to discuss tidal expiratory flow limitation and its effects, how to measure it noninvasively and effectively, and how using ventilators to minimize tidal EFL can produce physiological improvements. Along the way, they emphasis the importance of understanding respiratory physiology and respiratory mechanics.
Take a Breath: Performance of Mesh Nebulizers
Treating patients with COPD effectively can be a challenge. With their ability to literally take a breath acutely impaired, how can we help them get the right dose of inhaled bronchodilators? What kinds of devices might work better? The dose delivered by the InnoSpire Go mesh nebulizer was relatively unaffected by peak inhalation flow when tested using simulated breathing patterns with an I:E ratio representative of patients with severe COPD.
News and topics
Philips expands its Sleep & Respiratory Care portfolio with the acquisition of NightBalance
Events
Connect with us
Philips to attend ERS international Congress 2018
Paris, France September 15 - 19
Sleep & Respiratory Newsletter
Want to get more sleep and respiratory articles, news and information from Philips?
Explore the world of COPD insider
Can’t get enough information about COPD? At COPD insider, industry experts and those on the front lines of patient care come together to exchange ideas and insights to drive the transformation of COPD care. The biggest challenges deconstructed. Practical solutions for the entire treatment team. The latest clinical strategies. They all live right here at COPD insider. Here’s a sampling of what you can find: Insight such as: Dr. Teofilo Lee-Chiong, chief Pulmonologist and Chief Medical Liaison at Philip, discusses how emerging evidence has reinforced the use of home-based noninvasive ventilation (NIV) to treat patients with chronic hypercapnic COPD. Combination therapy has been shown to1:
Stay up to date with CME
Access new sleep and respiratory continuing medical education on the CHEST® Journal website (CHEST links require login) in the CHEST® CME Resource Center
1Murphy PB, Rehal S, Arbane G, et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. JAMA. 2017;317(21):2177-2186.
